169 related articles for article (PubMed ID: 828780)
1. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
2. [Drug therapy in hemoblastosis].
Bischof B
Folia Clin Int (Barc); 1968 Jun; 18(6):365-8. PubMed ID: 4988909
[No Abstract] [Full Text] [Related]
3. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
4. Cancer chemotherapy.
Smith LH
Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
[No Abstract] [Full Text] [Related]
5. Second malignancies and chemotherapeutic agents.
Kyle RA
Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
[No Abstract] [Full Text] [Related]
6. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
[TBL] [Abstract][Full Text] [Related]
7. [Experiences with methyl-benzyl-hydrazine (Natulan) in lymphoreticular diseases and hemoblastoses].
Schubert JC; Martin H
Blut; 1968; 18(1):42-7. PubMed ID: 4972003
[No Abstract] [Full Text] [Related]
8. Hematologic disorders in the elderly.
Walsh JR
West J Med; 1981 Dec; 135(6):446-54. PubMed ID: 6801866
[TBL] [Abstract][Full Text] [Related]
9. [Ambulatory treatment of hemoblastoses].
Vorob'ev AI; Brilliant MD
Ter Arkh; 1977; 49(8):3-9. PubMed ID: 929390
[No Abstract] [Full Text] [Related]
10. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
11. [Therapy of hemoblastoses. V. Plasmocytoma and macroglobulinemic reticulosis of Walderström].
Danieli G
G Clin Med; 1967 Feb; 48(2):164-74. PubMed ID: 4971622
[No Abstract] [Full Text] [Related]
12. [The treatment of chronic hemoblastosis with new cytostatic agents].
Quattrin N
Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
[No Abstract] [Full Text] [Related]
13. [Cytostatic therapy of hemoblastosis].
Ehrhart H
Pharmakotherapia; 1964; 2(1):59-88. PubMed ID: 5337120
[No Abstract] [Full Text] [Related]
14. [Results and current biological bases of therapy of malignant hemoreticulopathies].
Berceanu S; Gociu M; Geib R; Sighetea E; Dăncescu I; Segal E; Tănăsescu C
Stud Cercet Med Interna; 1971; 12(3):211-28. PubMed ID: 5002655
[No Abstract] [Full Text] [Related]
15. [Ambulatory treatment and check-ups of patients with hematologic diseases].
Kovaleva LG
Klin Med (Mosk); 1989 Aug; 67(8):127-32. PubMed ID: 2811233
[No Abstract] [Full Text] [Related]
16. [Drugs needed for treatment of patients with hemoblastosis].
Lebedev VN; Sarkisian SP
Probl Gematol Pereliv Krovi; 1977 Jun; 22(6):45-8. PubMed ID: 877053
[No Abstract] [Full Text] [Related]
17. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
Bladé J; Montoto S; Rosiñol L; Montserrat E
Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
[TBL] [Abstract][Full Text] [Related]
18. [Use of Imiphos in diseases of the blood system].
Pinus AG
Probl Gematol Pereliv Krovi; 1968 Aug; 13(8):26-31. PubMed ID: 5260223
[No Abstract] [Full Text] [Related]
19. [Indomethacin and hematopoiesis. Antipyretic and antiphlogistic effects in hemoblastoses and various uncommon diseases].
Treske U
Med Klin; 1968 Mar; 63(9):344-6. PubMed ID: 5247178
[No Abstract] [Full Text] [Related]
20. Adrenal steroids in the treatment of malignant hematologic disease.
Cline MJ
Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
